Henrik Vorum

6PUBLICATIONS
29CO-AUTHORS
NanomedicineOptical technologyMajor global burdens of diseaseGenome structure and regulationMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 27, 2026
Real-world insights on switching aflibercept dosage for enhanced outcomes in age-related macular degeneration (RISE-AMD): Safety data.

|Jan 10, 2026
CD8+ T cell aging is associated with macular neovascularization area change in neovascular age-related macular degeneration: a prospective cohort study.

Alexander Kai Thomsen, Maria Abildgaard Steffensen, Kathrine Gotfredsen

|Jul 14, 2025
Proteomic blood-biomarkers for personalized risk stratification of diabetic retinopathy patients.

Bent Honoré, Lasse Jørgensen Cehofski, Steffen Heegaard

|Jul 20, 2023
Diurnal proteome profile of the mouse cerebral cortex: Conditional deletion of the Bmal1 circadian clock gene elevates astrocyte protein levels and cell abundance in the neocortex and hippocampus.

Tenna Bering, Camilla Gadgaard, Henrik Vorum

|Mar 22, 2021
Aflibercept Intervention in Experimental Branch Retinal Vein Occlusion Results in Upregulation of DnaJ Homolog Subfamily C Member 17.

Lasse Jørgensen Cehofski, Anders Kruse, Alexander Nørgård Alsing

|Mar 15, 2018
Photonic modulation of epidermal growth factor receptor halts receptor activation and cancer cell migration.

Cláudia M Botelho, Odete Gonçalves, Rogério Marques

Pageof 1

Frequent Collaborators

4 joint publications

Bent Honoré

3 joint publications

Lasse Jørgensen Cehofski

1 joint publications

Cláudia M Botelho

1 joint publications

Odete Gonçalves